Tibet Pharmaceuticals, Inc. is a pharmaceutical company, which focuses on the research, development, manufacturing and marketing of modernized traditional Tibetan medicines. The company develops both prescription and over-the-counter traditional Tibetan medicines that promote health in human respiratory, digestive, urinary. The company was founded on December 22, 2009 and is headquartered in Diqing, China.
Company profile
Ticker
TBET
Exchange
Website
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Shangri-La Tibetan Pharmaceuticals, Inc.
SEC CIK
Corporate docs
Latest filings (excl ownership)
25-NSE
Exchange delisting
9 May 12
8-K
Tibet Pharmaceuticals, Inc. Announces Receipt of Non-Binding “Going Private” Proposal at $3.00 Per Share
1 Mar 12
8-K
Departure of Directors or Certain Officers
18 Jan 12
10-Q
2011 Q3
Quarterly report
14 Nov 11
8-K
Tibet Pharmaceuticals Announces Appointment of Sherb & Co., LLP as New Independent Auditor
18 Oct 11
8-K
Tibet Pharmaceuticals Announces Search for New Auditor Upon Resignation of ACSB
12 Sep 11
10-Q
2011 Q2
Quarterly report
15 Aug 11
8-K
Changes in Control of Registrant
10 Jun 11
10-Q
2011 Q1
Quarterly report
16 May 11
Latest ownership filings
No filings